WallStreetBets is renowned as a group focused on making some of the riskiest bets in the market. I usually scour the market for high-risk, high-reward bets.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Five 6-9% Low-Risk Yields To Avoid In May 2024

07:05am, Tuesday, 28'th May 2024
There are numerous stocks with safe and attractive high yields. There are several of them that we are avoiding right now, including a few that we recently sold. We share five that we are avoiding righ
Investors looking for dividend stocks have probably noticed Pfizer and Walgreens Boots Alliance offer above-average yields. Walgreens Boots Alliance stock is under pressure after shutting down an init
There is no joy like receiving passive income each quarter. I am someone who loves to receive dividend income and see my money grow without having to do anything.
A monthly chart of PFE using Worden's TC2000 Gold shows the stock oversold on a monthly basis. A stock with a 5.8-6% dividend yield in today's market immediately draws attention. Is the dividend susta

Pfizer: Turning The Corner (Rating Upgrade)

08:00pm, Sunday, 26'th May 2024
Pfizer's stock has hit bottom and could see a boost from bird flu fears. Covid-related sales now account for less than 15% of Pfizer's total revenues, de-risking the investment story. Pfizer is cuttin
Vertex Pharmaceuticals is in the midst of a major diversification plan. Eli Lilly's medicines for diabetes and obesity are incredibly hot sellers.
Pfizer sells more innovative new medicines than any of its peers. Pfizer has raised its dividend payout every year since 2009.
Pfizer's revenue and net income are moving in the wrong direction. However, the drugmaker has been rejuvenating its pipeline.
The "Sell in May and go away" adage suggests selling stocks in May and returning in November, but historical data shows that June and July have been strong months. September is consistently the worst
Pfizer's recent slump is understandable and not likely a long-term issue. Veeva Systems has a lot to offer its 1,400-plus customers, and they tend to stick around.
Pfizer stock is at its lowest price in over 11 years, presenting a potential buying opportunity. The company's valuation is near historically low levels, and consensus analysts expect earnings to stab
With many market strategists turning slightly bullish amid this bull market, investors may wonder if there's still any deep value left for the rest of us. Undoubtedly, not all companies have pulled th

3 Biotech Stocks to Buy on the Dip: May 2024

02:01pm, Thursday, 23'rd May 2024
Biotech is one of the most exciting industries to invest in right now. Companies have drugs on the market worth billions and continue to strive to produce the newest and best treatments in modern medi
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE